In vivo Evaluation of [²²⁵Ac]Ac-DOTA^ZOL for α-Therapy of Bone Metastases

E-ISSN： 1874-4729|11|3|223-230

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.11, Iss.3, 2018-12, pp. : 223-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Production of Ac-225

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 173-179

Bentham Science Publishers

Access to resources Recommend Favorite

Development of ²²⁵Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 156-172

Bentham Science Publishers

Access to resources Recommend Favorite

Bone Target Radiotracers for Palliative Therapy of Bone Metastases

Current Medicinal Chemistry, Vol. 19, Iss. 20, 2012-07 ,pp. : 3290-3300

Bentham Science Publishers

Access to resources Recommend Favorite

Saccharomonopyrones A–C, New α-Pyrones from a Marine Sediment-Derived Bacterium Saccharomonospora sp. CNQ-490

By Yim Chae-Yoon Le Tu Cam Lee Tae Gu Yang Inho Choi Hansol Lee Jusung Kang Kyung-Yun Lee Jin Sil Lim Kyung-Min Yee Sung-Tae Kang Heonjoong Nam Sang-Jip Fenical William

Marine Drugs, Vol. 15, Iss. 8, 2017-08 ,pp. : 239-239

MDPI

Access to resources Recommend Favorite

Targeted Therapy Options for Treatment of Bone Metastases; Beyond Bisphosphonates

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 3015-3027

Bentham Science Publishers

Access to resources Recommend Favorite